Biopharmaceutical company.
MCM development & procurement process; S. 1895, Lower Health Care Costs Act, provisions related to drug PRVs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 133, FY2021 Omnibus and COVID Relief and Response Act, funding for Public Health and Social Services Emergency Fund.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
901 K Street NW, Suite 900, Washington, DC, 20001, US
NICOLE CARELLI